文献速递肝病消化道肿瘤与早癌

多灶性肝细胞癌的基因组与肿瘤微环境异质性

Genomic and the tumor microenvironment heterogeneity in multifocal hepatocellular carcinoma.
PubMed 文献 · Hepatology · 2024-12-12

本研究对7例患者的23个样本进行全外显子组测序和单细胞RNA测序,刻画肝内转移(IM)与多中心发生(MO)的多灶性肝细胞癌(HCC)肿瘤微环境(TME)。IM恶性细胞瘤内异质性更高、干性更强、代谢更活跃,且IM与MO的TME不同;CD20+ B细胞、浆细胞和cDC2在IM中减少,IM中T细胞终末耗竭更明显;CD20和CD1C与更好预后相关;MMP9+肿瘤相关巨噬细胞在IM和MO中均富集并与Treg及增殖/耗竭T细胞形成细胞龛。

要点

  • IM恶性细胞比MO异质性更高、干性更强、代谢更活跃。
  • IM与MO的TME不同,IM中B细胞、浆细胞和cDC2减少。
  • IM中T细胞终末耗竭更明显,CD20和CD1C与更好预后相关。

核心结论

  • 研究深入解析了IM与MO之间异质的TME,提供了多灶性HCC的全面景观。

研究设计与样本

  • 对7例患者的23个样本行全外显子组测序和单细胞RNA测序,主要结果在额外队列中用免疫组化验证。

主要发现

  • IM恶性细胞比MO瘤内异质性更高、干性更强、代谢更活跃。
  • IM肿瘤TME相似,MO肿瘤TME不同。
  • CD20+ B细胞、浆细胞和cDC2在IM中较MO减少。
  • IM中T细胞终末耗竭更明显,增殖/耗竭T细胞比例高于MO。
  • MMP9+肿瘤相关巨噬细胞在IM和MO中均富集,与Treg及增殖/耗竭T细胞形成细胞龛。

关键数值与推荐

  • CD20和CD1C均与多灶性HCC更好预后相关。

临床怎么用

  • 识别IM与MO的TME差异有助于理解多灶性HCC的异质性,CD20和CD1C可能作为预后相关标志。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Ambiguous understanding of tumors and tumor microenvironments (TMEs) hinders accurate diagnosis and available treatment for multifocal hepatocellular carcinoma (HCC) covering intrahepatic metastasis (IM) and multicentric occurrence (MO). Here, we characterized the diverse TMEs of IM and MO identified by whole-exome sequencing at single-cell resolution. APPROACH AND RESULTS: We performed parallel whole-exome sequencing and scRNA-seq on 23 samples from 7 patients to profile their TMEs when major results were validated by immunohistochemistry in the additional cohort. Integrative analysis of whole-exome sequencing and single-cell RNA sequencing found that malignant cells in IM showed higher intratumor heterogeneity, stemness, and more activated metabolism than those in MO. Tumors from IM shared similar TMEs while distinct TMEs were noticed in those from MO. Furthermore, CD20+ B cells, plasma cells, and conventional type II dendritic cells (cDC2s) were decreased in IM relative to MO while T cells in IM exhibited a more terminally exhausted capacity with a higher proportion of proliferative/exhausted T cells than that in MO. Both CD20 and CD1C correlated with better prognosis in multifocal HCC. Additionally, MMP9+ tumor-associated macrophages were enriched across IM and MO, which formed cellular niches with regulatory T cells and proliferative/exhausted T cells. CONCLUSIONS: Our findings deeply decipher the heterogeneous TMEs between IM and MO, which provide a comprehensive landscape of multifocal HCC.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Yang Y, Ni Q, Li H, et al. Genomic and the tumor microenvironment heterogeneity in multifocal hepatocellular carcinoma. Hepatology. 2024. PMID: 40833995. doi:10.1097/HEP.0000000000001191

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。